Literature DB >> 6088334

The regulation of adenylate cyclase in adipocyte plasma membrane from genetically obese (ob/ob) mice.

R R French, D A York.   

Abstract

Adenylate cyclase activity was determined using a purified plasma membrane fraction prepared from isolated adipocytes by a Percoll gradient centrifugation procedure. The activation of adenylate cyclase by isoprenaline was reduced by approximately 50% in membranes from obese mice, although no reduction in the sensitivity of the response was apparent. Basal and fluoride- and 5'-guanylyl-imidodiphosphate-stimulated activities were similar in both groups. However, two defects in the obese system were identified which suggested that an alteration in the properties of the regulatory protein may account for the impaired hormonal activation. The specific binding of 3H-dihydroalprenolol to membranes from obese animals also was decreased, suggesting a reduction in the number of beta-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088334     DOI: 10.1007/bf00262223

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  A mitochondrial defect in brown adipose tissue of the obese (ob/ob) mouse: reduced binding of purine nucleotides and a failure to respond to cold by an increase in binding.

Authors:  J Himms-Hagen; M Desautels
Journal:  Biochem Biophys Res Commun       Date:  1978-07-28       Impact factor: 3.575

2.  Adenylate cyclase-coupled beta adrenergic receptors effect of membrane lipid-perturbing agents on receptor binding and enzyme stimulation by catecholamines.

Authors:  L E Limbird; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

3.  Saturation assay for cyclic AMP using endogenous binding protein.

Authors:  B L Brown; R P Ekins; J D Albano
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

4.  Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.

Authors:  G A Weiland; K P Minneman; P B Molinoff
Journal:  Mol Pharmacol       Date:  1980-11       Impact factor: 4.436

5.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

6.  Use of a novel rapid preparation of fat-cell plasma membranes employing Percoll to investigate the effects of insulin and adrenaline on membrane protein phosphorylation within intact fat-cells.

Authors:  G J Belsham; R M Denton; M J Tanner
Journal:  Biochem J       Date:  1980-11-15       Impact factor: 3.857

7.  alpha and beta-adrenoceptor coupling to adenylate cyclase.

Authors:  S R Nahorski
Journal:  Biochem Soc Trans       Date:  1982-12       Impact factor: 5.407

8.  Liver plasma membranes from essential fatty acid-deficient rats. Isolation, fatty acid composition, and activities of 5'-nucleotidase, ATPase and adenylate cyclase.

Authors:  R P Brivio-Haugland; S L Louis; K Musch; N Waldeck; M A Williams
Journal:  Biochim Biophys Acta       Date:  1976-04-16

9.  Adenylate cyclase in lean and obese (ob/ob) mouse epididymal white adipocytes.

Authors:  N Bégin-Heick
Journal:  Can J Biochem       Date:  1980-10

10.  An enzymatic defect in the obese (ob/ob) mouse: loss of thyroid-induced sodium- and potassium-dependent adenosinetriphosphatase.

Authors:  D A York; G A Bray; Y Yukimura
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

View more
  3 in total

1.  Regulation of polyunsaturated fatty acid metabolism in tissue phospholipids of obese (fa/fa) and lean (Fa/-) Zucker rats. 1. Effect of dietary lipids on cardiac tissue.

Authors:  K W Wahle; L Milne; G McIntosh
Journal:  Lipids       Date:  1991-01       Impact factor: 1.880

2.  Hepatic delta 6-desaturase activity in lean and genetically obese ob/ob mice.

Authors:  S Hughes; D A York
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

3.  Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors.

Authors:  S Reynisdottir; H Wahrenberg; K Carlström; S Rössner; P Arner
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.